Arbutus Biopharma Corporation · NASDAQ:ABUS

Morgan Stanley reported a 12.20% stake in Arbutus Biopharma Corporation (Schedule 13G/A)

Event Sep 30, 2026 · Filed Oct 7, 2026

Morgan Stanley reported a 12.20% stake in Arbutus Biopharma Corporation, 18,682,708 shares, as a passive investor on Sep 30, 2026. Filed Oct 7, 2026 (Schedule 13G/A).

Stake
12.20%
Shares
18,682,708
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley12.20%18,682,708
Morgan Stanley Investment Management Inc.11.30%17,376,366

Source

View original at SEC

Related